{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:00:26Z","timestamp":1785765626008,"version":"3.56.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1038\/s41418-026-01672-2","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:33:08Z","timestamp":1769819588000},"page":"1598-1616","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting the USP7-PRMT6 epigenetic axis overcomes chemoresistance in breast cancer by coordinating H3R2me2a deposition and RNF168 methylation for DNA repair and ferroptosis blockade"],"prefix":"10.1038","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7483-5822","authenticated-orcid":false,"given":"Tianshu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2563-255X","authenticated-orcid":false,"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0356-7075","authenticated-orcid":false,"given":"Weidong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"key":"1672_CR1","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1016\/S1470-2045(13)70567-9","volume":"15","author":"L Fan","year":"2014","unstructured":"Fan L, Strasser-Weippl K, Li JJ, St Louis J, Finkelstein DM, Yu KD, et al. Breast cancer in China. Lancet Oncol. 2014;15:e279\u2013289. https:\/\/doi.org\/10.1016\/S1470-2045(13)70567-9.","journal-title":"Lancet Oncol"},{"key":"1672_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106535","volume":"84","author":"K Barzaman","year":"2020","unstructured":"Barzaman K, Karami J, Zarei Z, Hosseinzadeh A, Kazemi MH, Moradi-Kalbolandi S, et al. Breast cancer: biology, biomarkers, and treatments. Int Immunopharmacol. 2020;84:106535. https:\/\/doi.org\/10.1016\/j.intimp.2020.106535.","journal-title":"Int Immunopharmacol"},{"key":"1672_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2021.0459","volume":"83","author":"C Katsura","year":"2022","unstructured":"Katsura C, Ogunmwonyi I, Kankam HK, Saha S. Breast cancer: presentation, investigation and management. Br J Hosp Med (Lond). 2022;83:1\u20137. https:\/\/doi.org\/10.12968\/hmed.2021.0459.","journal-title":"Br J Hosp Med (Lond)"},{"key":"1672_CR4","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/S0140-6736(05)66546-4","volume":"365","author":"U Veronesi","year":"2005","unstructured":"Veronesi U, Boyle P, Goldhirsch A, Orecchia R, Viale G. Breast cancer. Lancet. 2005;365:1727\u201341. https:\/\/doi.org\/10.1016\/S0140-6736(05)66546-4.","journal-title":"Lancet"},{"key":"1672_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2019-000504","volume":"4","author":"R Caparica","year":"2019","unstructured":"Caparica R, Lambertini M, de Azambuja E. How I treat metastatic triple-negative breast cancer. ESMO Open. 2019;4:e000504. https:\/\/doi.org\/10.1136\/esmoopen-2019-000504.","journal-title":"ESMO Open"},{"key":"1672_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41568-020-00308-y","volume":"21","author":"S Rottenberg","year":"2021","unstructured":"Rottenberg S, Disler C, Perego P. The rediscovery of platinum-based cancer therapy. Nat Rev Cancer. 2021;21:37\u201350. https:\/\/doi.org\/10.1038\/s41568-020-00308-y.","journal-title":"Nat Rev Cancer"},{"key":"1672_CR7","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrc2167","volume":"7","author":"L Kelland","year":"2007","unstructured":"Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer. 2007;7:573\u201384. https:\/\/doi.org\/10.1038\/nrc2167.","journal-title":"Nat Rev Cancer"},{"key":"1672_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-35795-8","volume":"14","author":"JM Lee","year":"2023","unstructured":"Lee JM, Hammaren HM, Savitski MM, Baek SH. Control of protein stability by post-translational modifications. Nat Commun. 2023;14:201. https:\/\/doi.org\/10.1038\/s41467-023-35795-8.","journal-title":"Nat Commun"},{"key":"1672_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2022.101097","volume":"86","author":"S Pan","year":"2022","unstructured":"Pan S, Chen R. Pathological implication of protein post-translational modifications in cancer. Mol Asp Med. 2022;86:101097. https:\/\/doi.org\/10.1016\/j.mam.2022.101097.","journal-title":"Mol Asp Med"},{"key":"1672_CR10","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1016\/j.molcel.2021.03.015","volume":"81","author":"EK Keenan","year":"2021","unstructured":"Keenan EK, Zachman DK, Hirschey MD. Discovering the landscape of protein modifications. Mol Cell. 2021;81:1868\u201378. https:\/\/doi.org\/10.1016\/j.molcel.2021.03.015.","journal-title":"Mol Cell"},{"key":"1672_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188903","volume":"1878","author":"G Saha","year":"2023","unstructured":"Saha G, Roy S, Basu M, Ghosh MK. USP7 - a crucial regulator of cancer hallmarks. Biochim Biophys Acta Rev Cancer. 2023;1878:188903. https:\/\/doi.org\/10.1016\/j.bbcan.2023.188903.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1672_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abq7598","volume":"8","author":"A Sijm","year":"2022","unstructured":"Sijm A, Atlasi Y, van der Knaap JA, Wolf van der Meer J, Chalkley GE, Bezstarosti K, et al. USP7 regulates the ncPRC1 Polycomb axis to stimulate genomic H2AK119ub1 deposition uncoupled from H3K27me3. Sci Adv. 2022;8:eabq7598. https:\/\/doi.org\/10.1126\/sciadv.abq7598.","journal-title":"Sci Adv"},{"key":"1672_CR13","doi-asserted-by":"publisher","unstructured":"Lin YT, Lin J, Liu YE, Chen YC, Liu ST, Hsu KW et al. USP7 induces chemoresistance in triple-negative breast cancer via deubiquitination and stabilization of ABCB1. Cells. 2022;11, https:\/\/doi.org\/10.3390\/cells11203294.","DOI":"10.3390\/cells11203294"},{"key":"1672_CR14","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201948597","volume":"21","author":"J Liu","year":"2020","unstructured":"Liu J, Feng J, Li L, Lin L, Ji J, Lin C, et al. Arginine methylation-dependent LSD1 stability promotes invasion and metastasis of breast cancer. EMBO Rep. 2020;21:e48597. https:\/\/doi.org\/10.15252\/embr.201948597.","journal-title":"EMBO Rep"},{"key":"1672_CR15","doi-asserted-by":"publisher","first-page":"368504221147173","DOI":"10.1177\/00368504221147173","volume":"106","author":"G Wang","year":"2023","unstructured":"Wang G, Wang JJ, Zhi-Min Z, Xu XN, Shi F, Fu XL. Targeting critical pathways in ferroptosis and enhancing antitumor therapy of Platinum drugs for colorectal cancer. Sci Prog. 2023;106:368504221147173 https:\/\/doi.org\/10.1177\/00368504221147173.","journal-title":"Sci Prog"},{"key":"1672_CR16","doi-asserted-by":"publisher","first-page":"5355","DOI":"10.1158\/0008-5472.CAN-19-0369","volume":"79","author":"L Tesfay","year":"2019","unstructured":"Tesfay L, Paul BT, Konstorum A, Deng Z, Cox AO, Lee J, et al. Stearoyl-CoA desaturase 1 protects ovarian cancer cells from ferroptotic cell death. Cancer Res. 2019;79:5355\u201366. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-0369.","journal-title":"Cancer Res"},{"key":"1672_CR17","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1158\/0008-5472.CAN-20-1488","volume":"81","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhao G, Condello S, Huang H, Cardenas H, Tanner EJ, et al. Frizzled-7 identifies platinum-tolerant ovarian cancer cells susceptible to ferroptosis. Cancer Res. 2021;81:384\u201399. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-1488.","journal-title":"Cancer Res"},{"key":"1672_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21963-1","volume":"12","author":"WJ Li","year":"2021","unstructured":"Li WJ, He YH, Yang JJ, Hu GS, Lin YA, Ran T, et al. Profiling PRMT methylome reveals roles of hnRNPA1 arginine methylation in RNA splicing and cell growth. Nat Commun. 2021;12:1946. https:\/\/doi.org\/10.1038\/s41467-021-21963-1.","journal-title":"Nat Commun"},{"key":"1672_CR19","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/s41589-022-01024-4","volume":"18","author":"Q Wu","year":"2022","unstructured":"Wu Q, Nie DY, Ba-Alawi W, Ji Y, Zhang Z, Cruickshank J, et al. PRMT inhibition induces a viral mimicry response in triple-negative breast cancer. Nat Chem Biol. 2022;18:821\u201330. https:\/\/doi.org\/10.1038\/s41589-022-01024-4.","journal-title":"Nat Chem Biol"},{"key":"1672_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2020.198076","volume":"286","author":"A Bojagora","year":"2020","unstructured":"Bojagora A, Saridakis V. USP7 manipulation by viral proteins. Virus Res. 2020;286:198076. https:\/\/doi.org\/10.1016\/j.virusres.2020.198076.","journal-title":"Virus Res"},{"key":"1672_CR21","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/s0092-8674(02)01199-6","volume":"111","author":"M Hu","year":"2002","unstructured":"Hu M, Li P, Li M, Li W, Yao T, Wu JW, et al. Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell. 2002;111:1041\u201354. https:\/\/doi.org\/10.1016\/s0092-8674(02)01199-6.","journal-title":"Cell"},{"key":"1672_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41418-024-01257-x","volume":"31","author":"B Zhang","year":"2024","unstructured":"Zhang B, Li J, Wang Y, Liu X, Yang X, Liao Z, et al. Deubiquitinase USP7 stabilizes KDM5B and promotes tumor progression and cisplatin resistance in nasopharyngeal carcinoma through the ZBTB16\/TOP2A axis. Cell Death Differ. 2024;31:309\u201321. https:\/\/doi.org\/10.1038\/s41418-024-01257-x.","journal-title":"Cell Death Differ"},{"key":"1672_CR23","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1093\/nar\/gkab154","volume":"49","author":"LY Huang","year":"2021","unstructured":"Huang LY, Hsu DW, Pears CJ. Methylation-directed acetylation of histone H3 regulates developmental sensitivity to histone deacetylase inhibition. Nucleic Acids Res. 2021;49:3781\u201395. https:\/\/doi.org\/10.1093\/nar\/gkab154.","journal-title":"Nucleic Acids Res"},{"key":"1672_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202202737","volume":"10","author":"T Yang","year":"2023","unstructured":"Yang T, Huang W, Ma T, Yin X, Zhang J, Huo M, et al. The PRMT6\/PARP1\/CRL4B complex regulates the circadian clock and promotes breast tumorigenesis. Adv Sci (Weinh). 2023;10:e2202737. https:\/\/doi.org\/10.1002\/advs.202202737.","journal-title":"Adv Sci (Weinh)"},{"key":"1672_CR25","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.cell.2012.08.005","volume":"150","author":"F Mattiroli","year":"2012","unstructured":"Mattiroli F, Vissers JH, van Dijk WJ, Ikpa P, Citterio E, Vermeulen W, et al. RNF168 ubiquitinates K13-15 on H2A\/H2AX to drive DNA damage signaling. Cell. 2012;150:1182\u201395. https:\/\/doi.org\/10.1016\/j.cell.2012.08.005.","journal-title":"Cell"},{"key":"1672_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116663","volume":"175","author":"KS Prabhu","year":"2024","unstructured":"Prabhu KS, Kuttikrishnan S, Ahmad N, Habeeba U, Mariyam Z, Suleman M, et al. H2AX: A key player in DNA damage response and a promising target for cancer therapy. Biomed Pharmacother. 2024;175:116663. https:\/\/doi.org\/10.1016\/j.biopha.2024.116663.","journal-title":"Biomed Pharmacother"},{"key":"1672_CR27","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/nature06166","volume":"449","author":"E Guccione","year":"2007","unstructured":"Guccione E, Bassi C, Casadio F, Martinato F, Cesaroni M, Schuchlautz H, et al. Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive. Nature. 2007;449:933\u20137. https:\/\/doi.org\/10.1038\/nature06166.","journal-title":"Nature"},{"key":"1672_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.841381","volume":"12","author":"Z Chen","year":"2022","unstructured":"Chen Z, Gan J, Wei Z, Zhang M, Du Y, Xu C, et al. The emerging role of PRMT6 in cancer. Front Oncol. 2022;12:841381. https:\/\/doi.org\/10.3389\/fonc.2022.841381.","journal-title":"Front Oncol"},{"key":"1672_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.101016","volume":"72","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Xia T, Chen DQ, Xiong X, Shi L, Zuo Y, et al. Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance. Drug Resist Updat. 2024;72:101016. https:\/\/doi.org\/10.1016\/j.drup.2023.101016.","journal-title":"Drug Resist Updat"},{"key":"1672_CR30","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1016\/j.chembiol.2024.08.003","volume":"31","author":"K Zhang","year":"2024","unstructured":"Zhang K, Wei J, Zhang S, Fei L, Guo L, Liu X, et al. A chemical screen identifies PRMT5 as a therapeutic vulnerability for paclitaxel-resistant triple-negative breast cancer. Cell Chem Biol. 2024;31:1942\u201357.e1946. https:\/\/doi.org\/10.1016\/j.chembiol.2024.08.003.","journal-title":"Cell Chem Biol"},{"key":"1672_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.molcel.2011.06.015","volume":"43","author":"M Werner","year":"2011","unstructured":"Werner M, Ruthenburg AJ. The United States of histone ubiquitylation and methylation. Mol Cell. 2011;43:5\u20137. https:\/\/doi.org\/10.1016\/j.molcel.2011.06.015.","journal-title":"Mol Cell"},{"key":"1672_CR32","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1093\/nar\/gkab209","volume":"49","author":"D Su","year":"2021","unstructured":"Su D, Wang W, Hou Y, Wang L, Yi X, Cao C, et al. Bimodal regulation of the PRC2 complex by USP7 underlies tumorigenesis. Nucleic Acids Res. 2021;49:4421\u201340. https:\/\/doi.org\/10.1093\/nar\/gkab209.","journal-title":"Nucleic Acids Res"},{"key":"1672_CR33","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.7150\/thno.69424","volume":"12","author":"C Zhang","year":"2022","unstructured":"Zhang C, Xu C, Gao X, Yao Q. Platinum-based drugs for cancer therapy and anti-tumor strategies. Theranostics. 2022;12:2115\u201332. https:\/\/doi.org\/10.7150\/thno.69424.","journal-title":"Theranostics"},{"key":"1672_CR34","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266\u201382. https:\/\/doi.org\/10.1038\/s41580-020-00324-8.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1672_CR35","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","volume":"29","author":"F Zanconato","year":"2016","unstructured":"Zanconato F, Cordenonsi M, Piccolo S. YAP\/TAZ at the roots of cancer. Cancer Cell. 2016;29:783\u2013803. https:\/\/doi.org\/10.1016\/j.ccell.2016.05.005.","journal-title":"Cancer Cell"},{"key":"1672_CR36","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-019-1426-6","volume":"572","author":"J Wu","year":"2019","unstructured":"Wu J, Minikes AM, Gao M, Bian H, Li Y, Stockwell BR, et al. Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling. Nature. 2019;572:402\u20136. https:\/\/doi.org\/10.1038\/s41586-019-1426-6.","journal-title":"Nature"},{"key":"1672_CR37","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202114351","volume":"13","author":"R Gao","year":"2021","unstructured":"Gao R, Kalathur RKR, Coto-Llerena M, Ercan C, Buechel D, Shuang S, et al. YAP\/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis. EMBO Mol Med. 2021;13:e14351. https:\/\/doi.org\/10.15252\/emmm.202114351.","journal-title":"EMBO Mol Med"},{"key":"1672_CR38","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/j.bbagen.2017.05.019","volume":"1861","author":"GO Latunde-Dada","year":"2017","unstructured":"Latunde-Dada GO. Ferroptosis: role of lipid peroxidation, iron and ferritinophagy. Biochim Biophys Acta Gen Subj. 2017;1861:1893\u20131900. https:\/\/doi.org\/10.1016\/j.bbagen.2017.05.019.","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"1672_CR39","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2018\/e478s","volume":"73","author":"CRR Rocha","year":"2018","unstructured":"Rocha CRR, Silva MM, Quinet A, Cabral-Neto JB, Menck CFM. DNA repair pathways and cisplatin resistance: an intimate relationship. Clin (Sao Paulo). 2018;73:e478s. https:\/\/doi.org\/10.6061\/clinics\/2018\/e478s.","journal-title":"Clin (Sao Paulo)"},{"key":"1672_CR40","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1158\/1078-0432.CCR-07-2238","volume":"14","author":"LP Martin","year":"2008","unstructured":"Martin LP, Hamilton TC, Schilder RJ. Platinum resistance: the role of DNA repair pathways. Clin Cancer Res. 2008;14:1291\u20135. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-2238.","journal-title":"Clin Cancer Res"},{"key":"1672_CR41","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1126\/science.1069398","volume":"296","author":"A Celeste","year":"2002","unstructured":"Celeste A, Petersen S, Romanienko PJ, Fernandez-Capetillo O, Chen HT, Sedelnikova OA, et al. Genomic instability in mice lacking histone H2AX. Science. 2002;296:922\u20137. https:\/\/doi.org\/10.1126\/science.1069398.","journal-title":"Science"},{"key":"1672_CR42","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.molcel.2005.12.002","volume":"20","author":"R Cao","year":"2005","unstructured":"Cao R, Tsukada Y, Zhang Y. Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. Mol Cell. 2005;20:845\u201354. https:\/\/doi.org\/10.1016\/j.molcel.2005.12.002.","journal-title":"Mol Cell"},{"key":"1672_CR43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2322972121","volume":"121","author":"LL Feng","year":"2024","unstructured":"Feng LL, Bie SY, Deng ZH, Bai SM, Shi J, Qin CL, et al. Ubiquitin-induced RNF168 condensation promotes DNA double-strand break repair. Proc Natl Acad Sci USA. 2024;121:e2322972121. https:\/\/doi.org\/10.1073\/pnas.2322972121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1672_CR44","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/annonc\/mdy127","volume":"29","author":"F Poggio","year":"2018","unstructured":"Poggio F, Bruzzone M, Ceppi M, Ponde NF, La Valle G, Del Mastro L, et al. Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis. Ann Oncol. 2018;29:1497\u2013508. https:\/\/doi.org\/10.1093\/annonc\/mdy127.","journal-title":"Ann Oncol"},{"key":"1672_CR45","doi-asserted-by":"publisher","unstructured":"Ho TC, Chang CC, Chan HP, Chung TW, Shu CW, Chuang KP et al. Hydrogels: properties and applications in biomedicine. Molecules. 2022;27. https:\/\/doi.org\/10.3390\/molecules27092902.","DOI":"10.3390\/molecules27092902"},{"key":"1672_CR46","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.cell.2009.05.050","volume":"138","author":"Y Wang","year":"2009","unstructured":"Wang Y, Zhang H, Chen Y, Sun Y, Yang F, Yu W, et al. LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. Cell. 2009;138:660\u201372. https:\/\/doi.org\/10.1016\/j.cell.2009.05.050.","journal-title":"Cell"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01672-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01672-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01672-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T13:15:53Z","timestamp":1785762953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01672-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1672"],"URL":"https:\/\/doi.org\/10.1038\/s41418-026-01672-2","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Animal handling and procedures were approved by the Army Medical University Institutional Animal Care (AMUWEC20234531). All human tissues were collected using protocols approved by the Ethics Committee of Shanghai Outdo Biotech Company (SHYJS-CP-1501011), and informed consent was obtained from all patients.","order":2,"name":"Ethics","label":"Ethics statement","group":{"name":"EthicsHeading","label":"Ethics"}}]}}